Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review B. GerberC. ScholzW. Janni Review 28 October 2005 Pages: 199 - 209
EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization Hui-Wen LoSheng-Chieh HsuMien-Chie Hung Review 28 October 2005 Pages: 211 - 218
Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer Gert G. Van den EyndenSteven J. Van LaereKenneth L. van Golen OriginalPaper 22 October 2005 Pages: 219 - 228
Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (Cytoxan) (AC) response and resistance Susan CleatorAnna TsimelzonJenny C. Chang Clinical Trails 02 December 2005 Pages: 229 - 233
Correlation of cyclooxygenase-2 and aromatase immunohistochemical expression in invasive ductal carcinoma, ductal carcinoma in situ, and adjacent normal epithelium Vilmar Marques OliveiraSebastião PiatoMaria Antonieta Longo Galvão Silva Epidemiology 02 December 2005 Pages: 235 - 241
Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling Steven J. Van LaereGert G. Van den EyndenLuc Y. Dirix Preclinical study 27 October 2005 Pages: 243 - 255
The serine-threonine protein phosphatase PPM1D is frequently activated through amplification in aggressive primary breast tumours Jenita RautaEmma-Leena AlarmoAnne Kallioniemi Preclinical study 28 October 2005 Pages: 257 - 263
Provasopressin expression by breast cancer cells: implications for growth and novel treatment strategies Brendan P. KeeganBonnie L. AkermanWilliam G. North Report 06 December 2005 Pages: 265 - 277
Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer Anne FleissigLesley J. FallowfieldRobert E. Mansel Clinical trial 15 September 2005 Pages: 279 - 293
